ICUI
ICU Medical, Inc.
Set alert
- YTD
- +14.80%
- 1 year
- +36.78%
- Open
- 167.90
- Prev close
- 168.65
- Mkt cap
- 4.10B
- Vol
- 216.56K
- Avg vol
- 261.90K
- EPS
- 1.19
- P/E
- 137.63
- Div yield
- 0.00%
More statistics
- Low
- 163.15
- High
- 167.90
- Forward P/E
- 16.97
- Beta
- 0.86
- Short ratio
- 6.84
- Inst. own
- 115.92%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 5, 2026
- 50-d avg
- 164.60
- 200-d avg
- 148.52
- 1y target
- 193.38
Key statistics
- Market cap
- 4.09B
- Enterprise value
- 5.20B
- Trailing P/E
- 137.60
- Forward P/E
- 16.97
- PEG ratio
- 0.08
- Price / sales
- 1.90
- Price / book
- 1.90
- EPS (TTM)
- 1.19
- Beta
- 0.86
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 1.39%
- Revenue (TTM)
- 2.16B
- Revenue growth
- 0.50%
- Free cash flow
- 163.56M
- Total cash
- 302.64M
- Total debt
- 1.29B
- Return on equity
- 1.41%
- Shares outstanding
- 25.01M
- Short % of float
- 8.20%
- 50-day average
- 164.60
- 200-day average
- 148.52
Analyst view
Consensus: buy
- Target (low)
- 178.00
- Target (mean)
- 193.38
- Target (high)
- 210.00
- Strong buy3
- Buy4
- Hold1
- Sell0
- Strong sell0
Next earnings
Nov 5, 2026
Expected Nov 5, 2026. Consensus EPS estimate 2.15.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 5, 2026 | Sep 30, 2026 | 2.14 | — | — | — |
| Aug 6, 2026 | Jun 30, 2026 | 1.91 | 2.37 | +0.46 | +24.08% |
| May 7, 2026 | Mar 31, 2026 | 1.78 | 1.97 | +0.19 | +10.67% |
| Feb 19, 2026 | Dec 31, 2025 | 1.68 | 1.91 | +0.23 | +13.69% |
| Nov 6, 2025 | Sep 30, 2025 | 1.43 | 2.03 | +0.60 | +41.96% |
| Aug 7, 2025 | Jun 30, 2025 | 1.44 | 2.10 | +0.66 | +45.83% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 7, 2026 | Piper Sandler | main | Overweight | Overweight |
| Aug 7, 2026 | BTIG | main | Buy | Buy |
| Aug 7, 2026 | Needham | main | Buy | Buy |
| Jul 21, 2026 | Keybanc | main | Overweight | Overweight |
| Jun 15, 2026 | BTIG | init | — | Buy |
| May 27, 2026 | Needham | up | Hold | Buy |
About ICU Medical, Inc.
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and administration of hazardous drugs; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; ClearGuard, SwabCap, and SwabTip disinfection caps; and vascular access products. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride, sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, such as outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- icumed.com
News
- ICU Medical Announces Time of Third Quarter 2026 Earnings Conference Call
- Head-To-Head Review: ICU Medical (NASDAQ:ICUI) & Beta Bionics (NASDAQ:BBNX)
- 3 Medical Product Stocks Positioned to Ride on the Industry Tailwinds
- ICU Medical, Inc. (NASDAQ:ICUI) Receives Consensus Recommendation of “Moderate Buy” from Analysts
- A Look at ICU Medical Inc (ICUI) After 3.7% Gain -- GF Value $121.40 vs Price $160.98
- Reviewing ICU Medical (NASDAQ:ICUI) & Ambu A/S (OTCMKTS:AMBBY)
- ICU Medical CFO Sells 6,381 Shares for $1.1 Million
- Critical Survey: ICU Medical (NASDAQ:ICUI) and Jushi (OTCMKTS:JUSHF)
- ICU Medical CFO Brian Bonnell Sells 9,307 Shares
- ICU Medical, Inc. (ICUI) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Your note
Sign in to keep a note on ICUI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABBEY DONALD M | Director | Conversion of Exercise of derivative security | May 12, 2026 | 6,004 |
| BONNELL BRIAN MICHAEL | Chief Financial Officer | Sale | Aug 31, 2026 | 56,062 |
| FINNEY ELISHA W | Director | Sale | Aug 10, 2026 | 4,871 |
| GREENBERG DAVID C | Director | Conversion of Exercise of derivative security | May 12, 2026 | 9,214 |
| HERNANDEZ LAURIE | Director | Conversion of Exercise of derivative security | May 12, 2026 | 4,862 |
| HOFFMEISTER DAVID F | Director | Conversion of Exercise of derivative security | May 12, 2026 | 6,004 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 15.02% | 3,753,409 | 614.60M | Jun 29, 2026 |
| Jupiter Topco LLC | 11.13% | 2,781,620 | 455.48M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.88% | 1,470,583 | 240.80M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 5.19% | 1,298,127 | 212.56M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.49% | 1,123,237 | 183.92M | Jun 29, 2026 |
| Dimensional Fund Advisors LP | 4.21% | 1,053,476 | 172.50M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| iShares Trust-iShares Core S&P Small-Cap ETF | 5.96% | 1,489,253 | 243.86M | Sep 29, 2026 |
| JANUS INVESTMENT FUND-Janus Henderson Enterprise Fund | 4.92% | 1,230,753 | 201.53M | Jun 29, 2026 |
| UNDISCOVERED MANAGERS Fd.S-Undiscovered Managers Behavioral Value Fd. | 4.22% | 1,054,324 | 172.64M | Jun 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.17% | 791,929 | 129.67M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.57% | 641,126 | 104.98M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.29% | 573,522 | 93.91M | Jun 29, 2026 |